John L Higgins, Ligand Pharmaceuticals Incorporated's Chief Executive Officer and a director of the company, recently acquired 33,790 shares of the company. The buys took place at $16.14 per share, on January 10, 2019. Higgins now owns 119,209 shares of the company. Higgins operates out of San Diego, CA. Some additional info was provided as follows:
Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 2/15/09.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!
Other recent filings from the company include the following: